The evolution of host immunity occurs in the context of the microbiome, but little theory exists to 13 predict how resistance against pathogens might be influenced by the need to tolerate and 14 regulate commensal microbiota. We present a general model to explore the optimal investment in 15
this effect can be reversed when pathogens increase host mortality. Generally, the magnitude of 23 costs of immunity required to allow evolution of decreased immune vigilance are predicted to be 24 lowest when microbiome and pathogen species most resemble each other (in terms of host 25 recognition), and when immune effects on the pathogen are weak. Our model framework makes 26 explicit the core trade-offs likely to shape the evolution of immunity in the context of microbiome / 27 pathogen discrimination. We discuss how this informs interpretation of patterns and process in 28 natural systems, including vulnerability to pathogen emergence. 29 30 Impact Summary 31
Evidence for impacts of the microbiome on host health is accumulating. Despite this, little theory 32 has been developed to delineate the evolutionary trajectories that might lead to observed host-33 microbiome associations. One particularly important theoretical gap is evaluating how the 34 presence and effects of microbiome species modify selection pressure on immune system 35 function. We develop a simple model of host fitness given both immune discrimination and 36 microbiome and pathogen effects on survival, in the context of an interaction between the 37 microbiome and pathogen species. We use this framework to predict when and to what degree 38 the presence of microbiome species might lead to loss of immune vigilance. Positive microbiome 39 effects can drive loss of immune vigilance, whether the microbiome acts directly on pathogen 40 growth or indirectly by reducing the impacts of pathogens; and high costs of immunity will amplify 41 this effect. Our results provide a first set of predictions regarding how immunity should evolve 42
given the challenge of discriminating pathogen and microbiome species, and reveals the ways in 43 which this might leave hosts vulnerable to novel pathogens. 44 Introduction 46
Bacterial species making up the microbiome are increasingly recognized to play an important role 47 in host health, including via microbiome-mediated protection against pathogens (Friesen et al. 48 2011 ). An important implication is that the evolution of host immunity must have occurred in the 49 context of balancing tolerance of commensals and resisting pathogens (Littman and Pamer 50 2011). As a result, underlying ecological features of both hosts and bacteria will define how 51 selection shapes host immunity across host generations. For example, microbiome-mediated 52 protection might evolve very rapidly, due to both shorter microbial generation times and greater 53 standing genetic variation. The resulting protection against pathogens enjoyed by the host might 54 hinder the evolution of host genetic resistance (King and Bonsall 2017) . Growing evidence also 55 suggests that the microbiome plays a critical role in shaping the breadth and specificity of host 56
immunity (Thaiss et al. 2016 ). This will also shape selection pressures on host immunity to resist 57 pathogens. Despite increasing recognition of the importance of the microbiome in host ecology 58 and health, mathematical models of core processes remains rare, and there is little theory to 59 guide expectations (Koskella, Hall, and Metcalf 2017) . 60 61
To adequately reflect natural systems of interest, mathematical models must capture several 62
interlocking aspects of the ecology and co-evolution underpinning microbiome-mediated 63 protection. Here, we focus our investigation on innate immunity, the first line of defense against 64 pathogens, found across species from plants to vertebrates. We ask how the presence of 65 commensal microbiota might shape selection on how hosts trigger innate immunity. Innate 66 immunity would ideally be launched when molecular signatures of pathogens were detected. 67
Since pathogens will rapidly evolve away from any signature that is detectable by innate 68 immunity, and that is not subject to constraints, typically, the molecular signatures used by innate 69 immunity are highly conserved among bacteria. The bacterial flagellin protein is a classic 70 example (Gómez-Gómez and Boller 2002) -this apparently tightly constrained structure is widely 71 used by hosts as a strong trigger of host innate immunity (Felix et al. 1999 ). Importantly, the 72 result is that pathogens and commensal microbiota are likely to have overlapping expression of 73 molecules used by the host in detection of pathogens (Levy et al. 2018; Vogel et al. 2016 ). The 74 decision to trigger an immune response must therefore discriminate between the presence of 75 pathogens and (neutral or even beneficial) microbiota despite these similarities. Hosts are left 76 with a fundamental tension between maintaining a diverse microbiome and defending against 77 pathogens despite these similarities. This tension remains poorly understood. 78 79
The problem is further complicated by the ability of many commensal microbiota to play a role in 80 host defense by either excluding pathogen colonization and growth, or reducing the impact of 81 pathogens on host health (Snelders et al. 2018 ). This might (or might not) echo molecular 82 signatures underlying detection by immunity, for example if phylogenetically related pathogenic 83 and commensal bacteria were more likely to compete for shared resources and were recognized 84 by the immune system through shared mechanisms. In this case, reducing immune vigilance may 85 allow for the proliferation of particular commensal microbiota that directly compete with invading 86 pathogens, reducing the need for hosts to invest in immunity (Hrček et al. 2018; Jaenike 2012) . 87
Many lines of evidence suggest that triggering an immune reaction is likely to be costly (Hanssen 88 et al. 2004; Sheldon and Verhulst 1996) and thus walking the line between effective pathogen  89  defenses and regulating microbiome homeostasis should be a ubiquitous but non-trivial  90  challenge.  91  92 Here, we ask how host innate immunity might evolve in the presence of a commensal microbiota 93
with the potential to diminish pathogen impact on the host via competition. Since many molecules 94 used by hosts to trigger innate immunity are evolutionarily constrained (e.g., flagellin (Gómez-95
Gómez and Boller 2002)), we initially assume that evolution in pathogen and commensal 96 microbiota communities is negligible. We capture the impacts of pathogen and commensal 97 microbiota on fitness through a simple mapping from their abundance to host survival (rather than 98 developing a complete dynamical description of the interactions between pathogens, commensal 99 microbiota and host immunity; e.g., as in (Leung and Weitz 2019)). To capture the discrimination 100 problem faced by innate immunity, we assume that pathogens and commensal microbiota can be 101 reflected as being distribution along a single axis, representing a range from a 'small' to a 'large' 102 signal detectable by the immune system, which might reflect aspects such as the number of CpG signatures of 'stress' or deviation from homeostasis more broadly (Chovatiya and Medzhitov 108 2014)). From this, we develop a model framework constructed around core principles from 109 epidemiology to better understand the drivers of the evolution of host defense in the context of 110 pathogen-microbiome interactions. We aim in particular to delineate the conditions under which 111 the presence of commensal microbiota may result in loss of immune vigilance altogether. Our 112 results show that loss of vigilance driven by protective microbiota is possible, and its likelihood 113 increases as similarity between the commensal microbiota and pathogen communities increases, 114
and when immune effectiveness against the pathogen is weak. We discuss how evolution by 115 pathogen and commensal microbiota communities might modulate outcomes for the host, and 116 how these consequences might play out across host life histories. 117 118
Methods and Results 119 120
A discrimination trade-off 121
The problem faced by the immune system in discriminating between 'good' commensals and 122 'bad' pathogens is analogous to a classic challenge from epidemiology. Overlap between two 123 categories along a continuum means that choosing where to draw a line to discriminate between 124 them results in a trade-off between falsely allocating individuals to one or the other category 125 ( Figure 1 ). In this example, the two distributions correspond to the community of commensal 126 microbiota (left) and pathogenic microbiota (right); the height of the two distributions reflects the 127 number of individuals in each category corresponding to each value along the continuum (e.g. 128
shared flagellin characteristics). The immune strategy under selection corresponds to the 129 problem of where to draw the line above which an immune reaction is triggered. If we define the 130 commensal microbiota as the community of microbial species with positive effects, ideally, the 131 line would have all individuals from this community to its left, where no immune response is 132 triggered, and all pathogenic microbiota to its right, where immunity acts to clear microbial 133 species. However, the predicted overlap between these two communities means that this would 134 be impossible. Drawing the line to the far left of the plot corresponds to a strategy of 'total 135 vigilance,' where every single microbe along the continuum triggers a reaction (with associated 136 costs of immune response). We refer to this as "100% vigilance". Drawing the line to the far right 137 of the plot corresponds to a strategy of 'no vigilance', where no microbe elicits an immune 138
reaction. If there is overlap between the two distributions, drawing the line towards the middle of 139 the plot (e.g., the intermediate strategy illustrated in Figure 1 ) inevitably mis-classifies some 140
individuals: some members of the commensal microbiota will be above the line, and some 141 members of the pathogenic microbiota below it. The strategy that maximizes fitness will balance 142 costs of immunity with costs and benefits of pathogens and commensal microbiota, and the effect 143 of their overlap, i.e., the impact of the commensal microbiota on the pathogen relative to 144 outcomes for the host. 145 146
This framing reduces the effects of immune discrimination and competition between commensal 147
and pathogenic bacteria to being organized along a single dimension (the x axis on Figure 1 ); 148
and furthermore assumes that all microbial species classified as 'commensal' and all those 149 classified as 'pathogenic' have identical effects on host fitness. Both these features are 150 simplifications. If, for example, the beneficial effect of commensal species is highest for those 151 species that most resemble the pathogenic species, this will considerably alter the optimal 152 threshold for an immune response, as it will no longer make sense to sacrifice some of these 153 beneficial species to control the pathogenic species. Nevertheless, it provides a starting point for 154 framing the challenges faced by immunity, and might be appropriate if variation along the scale of 155 discrimination available to the immune system (x axis on Figure 1 ) overwhelms the individual 156 species differences in terms of effects on the host within the categories commensal and 157 pathogenic microbiota. 158 159
Defining survival probability in the context of a discrimination trade-off 160
To move from our conceptual mapping of the challenge faced by the immune system ( Figure 1 ) 161 to a measure of host fitness, we express host survival as the outcome of mortality hazards 162 associated with each context. We can express the hazard of mortality for an individual as:
where the quantities A, B, C, D, E, and F refer to areas as shown on Figure 1 (A+B+C+D 167 captures the areas occupied by the pathogenic microbiota, and E+F areas occupied by the 168 commensal microbiota); # is a baseline mortality hazard, & is the mortality hazard associated 169
with the presence of the pathogenic species (and corresponds to their 'virulence'), . is the 170 mortality hazard associated with the presence of the commensal microbiota (and is either zero or 171 negative).The parameter + captures the host's resistance to the pathogenic microbiota, e.g., its 172 ability to reduce the mortality hazard associated with the presence of pathogenic species to the 173 right of the immune threshold line. This parameter is contained between 0 and 1, where + = 1 174 indicates no effect of the host on the pathogenic species' impact, and + = 0 indicates that the 175 host completely eliminates the effects of the pathogenic species. For completeness, . captures 176 how much the host reduces the effect of the commensal microbiota. Where the microbiome has 177 beneficial effects on survival ( . < 0) this will translate into the host tolerating their commensal 178 microbiota if + = 1, and eliminating the beneficial effects if + = 0. The parameter captures the 179 degree to which the presence of the commensal microbiota reduces the mortality hazard by the 180 pathogenic microbiota (e.g., by outcompeting or interfering with them) in a manner dependent on 181 their overlap along the continuous axis used by the host. This parameter is also contained 182 between 0 and 1, with larger values indicating less effective competition by the microbiome. The 183 parameter captures the cost of an immune response, and is multiplied by all contexts where an 184 immune reaction has been triggered (e.g., area to the right of the vertical line, shaded yellow, 185 Figure 1 ). 186 187
To evaluate the outcome of different scenarios for the host, each mortality hazard must be 188 multiplied by the relevant area reflecting the combination of the distribution of commensal and 189 pathogenic microbiota, and the positioning of the immune threshold, as labelled on Figure 1 ; with 190
A, the area below the threshold for immunity consisting of only the pathogen; B the area below 191 the threshold where the pathogenic microbiota overlaps with the commensal microbiota; C, the 192 area above the threshold where only the pathogenic microbiota is present; D, the area above the 193 threshold where both pathogenic and commensal microbiota are present ( Figure 1 ); E, the area 194
where the commensal microbiota is below the threshold; and F, the area where the commensal 195 microbiota is above the threshold and thus potentially eliciting an immune response. An 196
individual's probability of survival, as a function of the presence of the pathogen and its immune 197 threshold can then be expressed by = (− ). 198 199
Selection on the immune threshold 200
Assuming that fertility is not affected by either the microbiota or the immune strategy adopted by 201 the host, maximising survival will maximize host fitness. We can evaluate evolutionary outcomes 202 schematically, mapping out how different contributions to the hazard change as the threshold 203 moves from left (complete immune vigilance) to right (no immune vigilance), and from this, 204 characterize how increases in each of the contributions to the mortality hazard modulates the 205 optimal immune threshold, which is defined by the strategy corresponding to the lowest summed 206 hazard and thus highest survival ( Figure 2 ). This indicates that high costs of immunity, or positive 207 effects of the microbiome could shift the optimal towards 'no vigilance' (i.e., drive hosts towards 208 the evolution of no immunity). Indirect effects of the commensal microbiota on pathogen growth, 209
for example, whereby commensal microbiota competition reduces pathogen hazard, could also 210 have this effect. 211 212
Using basic probability, we can calculate the areas A-F. For simplicity, we can first evaluate 213 outcomes where the two distributions are perfectly overlapping. This also captures the scenario 214
where the pathogenic microbiota has evolved to be indistinguishable from the commensal As the immune threshold moves from left to right, reflecting a transition from complete vigilance 220 by the immune system to no vigilance at all, the magnitude of the area denoted B increases 221 (Figure 1) . As a result, the sign of the factor multiplying B will determine whether the outcome of 222 evolution in the presence of a commensal microbiota is effectively the absence of an immune 223 response or a complete immune response (we expect purely binary outcomes in this simple 224 scenario). From this, selection for no vigilance requires that:
This relationship indicates that the cost of immunity ( ) required to drive evolution in the host 229 towards a strategy of no immune vigilance will increase: (i) as the hazards increase (whether 230 associated with the commensal microbiota or the pathogenic microbiota); (ii) when the effect of 231 competition from the commensal microbiota on the pathogenic microbiota is reduced (reflected by 232 increased values of c); or (iii) if the impact of immunity on the hazards is increased (reflected by 233 decreased values of either . or + ). 234 235
Focusing on the magnitude of immune cost (I) required to drive complete loss of immune 236 vigilance provides a tractable focus for understanding life history constraints (given the array of 237 potential parameters), as well as being of biological interest. Extending results presented in eqn 238
[3] numerically ( Figure 3A) , we can plot the magnitude of the cost of immunity ( ) required for 239 evolution to the point of no immune vigilance across a spectrum of commensal and pathogenic 240 microbiota-mediated hazards, and across a range of overlaps between commensal and 241 pathogenic microbiota ( Figure 3B, x axis) . The required immune cost associated with loss of all 242 immune vigilance increases as overlap declines ( Figure 3B , y axis), with higher costs required for 243 lower pathogen hazards ( Figure 3B, colours) , or in the presence of a commensal microbiota 244
( Figure 3B , line types); and costs decline with diminishingly effective pathogen immunity + 245
( Figure 3B , left to right panels). 246 247
How will competition shape the evolution of immune vigilance? To explore this, we can evaluate 248 survival at a range of immune thresholds in the absence ( = 1, Figure 4 , left) versus presence 249 ( = 0, FIgure 4, right) of competition across a spectrum of pathogenic microbiota hazard and 250 immune effectiveness against pathogens (Figure 4 , line types, text) for different costs of immunity 251 (purple colours indicate higher costs). If mortality caused by pathogenic microbiota is low, and/or 252 immune effectiveness is high, the optimal strategy is no immune vigilance (Figure 4 , dashed line 253 peaks to the right) and is not much modulated by competition (compare left and right panels). For 254 intermediate pathogenic microbiota mortality / immune effectiveness, the optimal strategy is 255 complete vigilance in the absence of competition (Figure 4 and further, alters the optimal to being no immune vigilance, with this reflecting a considerable 264 survival advantage (Figure 4 , right, solid line peaks to the right). 265 266
In results presented to this point, we have effectively assumed that the abundance of commensal 267 and pathogenic microbiota are equal. In reality, pathogenic species are likely to be considerably 268 more rare. Altering results to encompass lower abundance in the pathogenic microbiota 269 community (equivalent to reducing the height of the red distribution on Figure 1 ) results in a 270 qualitatively similar results, but with loss of immune vigilance achieved at lower levels for 271 comparable parameter sets. 272 273
Dysbiosis at high or low diversity 274
In many settings, reduced microbiome diversity has been linked to 'dysbiosis', or reduced health 275 as a result of perturbed microbiome ecology. However, in others, such as the vaginal 276 microbiome, evidence suggests that reduced diversity is in fact a sign of health. To better capture 277
how the impacts of microbiome diversity shape selection on immune system response, we 278 assume that the range of diversity left intact in the wake of immune activity (e.g., values to the left 279 of the threshold for the immune response, Figure 1 ) affects the overall hazard. Diversity is 280 measured using Simpson's diversity index, 281 282
where n is the number of individuals of each species (identified as positions along the x axis on 285 Figure 1) and N is the total number of individuals, in both cases taking only points below the 286 threshold. This index thus represents the probability that two individuals randomly selected from a 287 sample will belong to different species, and is thus essentially a saturating function of the position 288 of the threshold from left to right, saturating at 1. 289 290
The effect of diversity on the hazard ..&HI may be either negative or positive, and thus may 291 increase or decrease the mortality hazard. The expression for the mortality hazard becomes: Conceptually, this corresponds to adding one more curve to the schematic of hazards in Figure 2 , 296 either increasing (where the hazard increases with diversity) or decreasing (where the hazard 297 decreases with diversity). This illustrates that where dysbiosis increases as diversity declines 298 (e.g., as in (Lawley et al. 2012) ), this will select for a decline in immune vigilance; and vice versa. 299 300
Again, as discussed in introducing the framework (Figure 1) , this neglects the important fact that 301 some species may be far more important than others in terms of their effects on the host; and as 302 in the previous case, how diversity shapes the optimal immune discrimination might be 303 substantially altered by this. 304 305 306 307
Discussion

308
We provide a first framing of how the presence of microbiome species might modulate the 309 evolution of innate immunity where the immune system faces the challenge of discriminating 310 between pathogenic and other microbe species (Figure 1 ). We separate out direct positive effects 311 of the microbiome on reducing mortality (even in the absence of infection) with indirect effects 312 from competing with and reducing mortality effects of pathogenic species (captured by the 313 parameter c). We show that either effect can shift the evolution of host immunity towards loss of 314 vigilance; that the effects are amplified as similarity between the microbiome and pathogen 315 communities increases ( Figure 3B, x axis) ; and that when immune effectiveness against the 316 pathogen is weak ( Figure 3B, right Although we discuss our results in microbiome community terms, where all commensal and 335 pathogenic microbiota have the same (positive or negative) effect on the host, our broad 336 conclusions will hold for a single pathogenic species, with some small distribution along the 337 possible immune trigger, or a single commensal species, likewise. The tension between paying 338 the costs of immunity and those of harbouring pathogenic microbiota will play out even if the non-339 pathogenic microbiota considered are neutral (Figure 3 ). For tractability, our framing also 340 collapses the possible triggers for immunity to a single axis (Figure 1) Both these aspects suggest that although a single dimension may not perfectly reflect how 347 microbial species trigger immunity, it provides a reasonable starting point; albeit one perhaps 348 most relevant considering interactions happening within kingdoms (bacterial pathogens with 349 bacterial microbiome, viral pathogens with virome, and fungal pathogens with mycobiome), given 350
higher potential for overlap of shared immune mechanisms). 351
352
Our primary focus here is on innate immunity, but the front line of defense in many organisms, for 353 many species, is adaptive immunity, especially in protecting hosts from re-exposure to parasites. 354 Nevertheless, cross-talk with innate immunity remains a crucial element in the activation of 355 adaptive immunity (Iwasaki and Medzhitov 2015) , so the trade-offs introduced here are likely to 356 still be relevant. Furthermore, this framing raises interesting questions about how the challenge of 357 distinguishing pathogenic from neutral or commensal microbes intersects with the intricate 358 evolution of tolerance of microbiome species displayed by adaptive immunity in vertebrates 359 (Cebula et al. 2013 ). On the time-scales of host ontogeny, introduction of commensal species 360 outside of a critical window of exposure could lead to a host either excluding a potentially 361 protective microbiome species, or mounting an immune defense against non-pathogenic bacteria 362 in a way that leads to autoimmunity (Gensollen et al. 2016 ). 363 364
Across the field, a focus on host evolution relative to pathogen (or microbiome) characteristics 365 remains relatively rare, as the shorter time-scales of microbe generations suggest much more 366 rapid selection. Nevertheless, hosts indubitably do respond to pathogen selection, and by 367 focusing on highly conserved aspects of microbe molecular make-up, we narrow the time-scale 368 mismatch in this co-evolutionary process. Yet, while our focus is on host evolution, we can also 369 evaluate our results in the context of microbe evolution. In particular, the situation of completely 370 overlapping pathogen and microbiome species distributions (equation [3]) captures the situation 371
where the pathogen has evolved to be completely indistinguishable from the microbiome. Another 372 potential direction for coevolution is selection for signaling by commensal microbiota to facilitate 373 recognition by adaptive immunity (Ost and Round 2018), equivalent to increasing the separation 374 between the two distributions in Figure 1 . Both microbiome and pathogen species might also be 375 able to evolve to evade immune detection altogether. Modifying our model to include a lower 376 bound on where the immune threshold can be drawn (e.g., in Figure 1 , the vertical purple line can 377 no longer go all the way to the right) will account for this by bounding the optimal strategy that the 378 host can evolve -qualitative predictions of our model are unchanged. 379 380
Longevity or 'pace of life' is often a focal explanatory variable when evaluating the evolution of 381 immunity (Martin, Weil, and Nelson 2007) . Here, if the abundance of commensal and pathogenic 382 microbiota is constant across the life-cycle, then we expect no changes in strategy with longevity, 383 since all extra hazards are essentially an extra extrinsic mortality hazard (Caswell 2007 ). 384
However, in reality, rare microbiota may be less likely to colonize hosts, resulting in a later age of 385 their acquisition. Thus, if pathogenic microbiota are rare, they are likely to be acquired after 386 commensal or neutral microbiota. Given the potential for competition from already-present 387 commensal or neutral microbiota, and the ubiquitous effect of declining selection pressures with 388 age (Hamilton 1966) , this could amplify selection for loss of immune vigilance. Yet, longevity is 389 likely to intersect with many other aspects of microbe ecology. In particular, longer lived species 390 might encounter a higher diversity of microbes, simply given longer exposure times during which 391 microbe colonization can occur. Where most microbial species have neutral effects, longer lived 392 species are predicted to retain immune vigilance, all else being equal, since the cumulative costs 393 of pathogens (even if rare) will translate into a significant reduction in long-lived host reproductive 394 value relative to shorter lived species. An increase of dysbiosis with microbe diversity will tend to 395 amplify this effect (noting, however, that the reverse pattern is often reported). Since many 396 features, including costs of immunity might also covary with longevity, careful titration of selection 397
pressures will be required to evaluate the strength of this prediction in natural systems. 398 399
Since protective effects of microbiome species are predicted to drive the loss of host immune 400 vigilance, hosts could be left vulnerable to attack by novel pathogens that too closely resemble 401 allies that the host has been selected to ignore. Conversely, if the presence of protective bacteria 402 actually covaries with the presence of pathogens, it has recently been shown that this can result 403 in increased host investment in resistance occurring in tandem with the presence of protective 404 symbionts (Hrček et al. 2018) , again emphasizing that the details of microbial ecology matter. 405 406
To conclude, while our framework makes a number of simplifying assumptions (e.g., ignoring 407 immune responses triggered by tissue-specific damage, a widely observed phenomenon; and 408 collapsing of potentially multidimensional immune discrimination), it makes a first set of 409 predictions about optimal immune discrimination, both as a function of overlap between pathogen 410
and microbiome, and of microbiome-mediated protection. This initial framing lays a foundation for 411 future work exploring the under-studied question of selection on host immunity in light of our 412 expanding understanding of the microbiome. It also brings to light the need for more explicit data 413 examining the overlap in host recognition of pathogens and commensal microbiota. 414 415
Author Contributions: CJEM and BK developed the concept; CJEM developed the models; 416 CJEM and BK wrote the paper. 417 418 419 420 increasing the optimal vigilance. Conversely, increases in the costs of immunity, or loss of 451 impacts of a beneficial microbiota will shift the threshold to the right, thus decreasing optimal 452 vigilance (purple and blue arrows, respectively). Competition (parameter c) and immune effects 453 (rp and rm ) are not illustrated here because their effect may be context specific (Figure 3 ). is the value of (purple box) required to tip the quantities on the right of the scales (i.e., the 459 components of the hazard that decline as the immune threshold moves right and immune 460 vigilance falls), below the quantities on the left (i.e., components that increase in value as the 461 immune threshold moves right). The effect of overlap between commensal and pathogenic 462 microbiota communities, governed by the competition parameter, , contributes to both sides of 463 the scale (red boxes). B) As the overlap between commensal and pathogenic microbiota 464
Figure 1: Schematic of overlap between commensal microbiota (left, blue) and pathogenic
communities increases (x axis shows proportion overlap between the two distributions), the cost 465 of immunity required to drive evolution to no immune vigilance (y axis) decreases. All else equal, 466 the cost is greatest for large pathogen hazards (darker red colours) in the absence of commensal 467 microbiota (solid line corresponding to . = −0.2; with . = 0 for the dashed line; other 468 parameters are . = 0.3, = 0.5). Reducing the effectiveness of immunity in reducing the hazard 469 associated with pathogen microbiota (by moving from + = 0.1 left panel, to + = 0.7 right panel, 470
corresponding to ineffectual immunity) results in lower costs allowing loss of host immunity (far 471 right). If the pathogenic microbiota community is rarer than the commensal microbiota community 472 (corresponding to a reduction in the height of the pathogen distribution in Figure 1 
